it comes in at around #64 in the top 100.
Now it does. Because it's about to run.
Also the disclosures on the shorters list are unregulated and probably understated.
Ann: Mesoblast Phase 3 CLBP Trial Completes Enrollment, page-105
Add to My Watchlist
What is My Watchlist?
